ArticleBriefings in bioinformatics2025
SAGE-prot: scoring-assisted generative exploration for multi-objective protein design.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From Algorithms to Assets: A Comprehensive Review of AI's Role in Preclinical Drug Discovery and the Hurdles to Clinical Translation.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Protein Design Enters the Artificial Intelligence Era: Foundations, Tools, and Emerging Paradigms.Computational and structural biotechnology journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Designing proteins with multiple optimized properties remains a fundamental challenge in biotechnology, especially when design objectives exhibit trade-offs or when structural templates are unavailable. We present scoring-assisted generative exploration for proteins (SAGE-Prot), a modular and extensible protein design framework that integrates autoregressive sequence generation, genetic algorithm(GA)-based diversification, and scoring-guided property evaluation in a closed-loop optimization process. Unlike conventional approaches, SAGE-Prot performs optimization directly at the sequence level without relying on structural templates for generation, while enabling structure-aware evaluation. Across rediscovery and similarity benchmarks involving 10 therapeutic proteins, hybrid language model/GA strategies implemented in SAGE-Prot consistently outperformed language model-only and heuristic baselines. Applied to two design problems, protein G domain B1 optimization for binding affinity and thermal stability, and TEM-1 β-lactamase optimization for enzymatic activity and solubility, SAGE-Prot effectively identified high-performing variants guided by predictive models trained on diverse sequence- and structure-derived descriptors. A curriculum learning (CL) strategy further accelerated convergence and improved design quality. Notably, experimental validation of six SAGE-Prot-designed TEM-1 β-lactamase variants confirmed up to a 752-fold increase in catalytic activity, underscoring the practical utility of this generative framework. These results highlight how coupling deep generative modeling with structure-informed evaluation and iterative fine-tuning enables generalizable, data-driven protein engineering across diverse optimization landscapes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.